Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.

J Gen Intern Med. 2004 Feb;19(2):146-55.

PMID:
15009794
2.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
3.

Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.

Hayn MH, Orom H, Shavers VL, Sanda MG, Glasgow M, Mohler JL, Underwood W 3rd.

Cancer. 2011 Oct 15;117(20):4651-8. doi: 10.1002/cncr.26103.

PMID:
21456009
4.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

PMID:
15612083
5.

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL.

J Natl Cancer Inst. 2001 Mar 7;93(5):388-95.

PMID:
11238701
6.

Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).

Chhatre S, Bruce Malkowicz S, Sanford Schwartz J, Jayadevappa R.

Medicine (Baltimore). 2015 Aug;94(32):e1353. doi: 10.1097/MD.0000000000001353.

PMID:
26266389
7.

Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.

Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W.

Cancer. 2006 Mar 15;106(6):1276-85.

PMID:
16475208
8.

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL.

J Geriatr Oncol. 2014 Oct 1;5(4):352-8. doi: 10.1016/j.jgo.2014.05.001.

PMID:
24862107
9.

Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.

Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB, Lo M, Ho A, Anderson RT, Thompson T.

Am J Clin Oncol. 2016 Feb;39(1):55-63. doi: 10.1097/COC.0000000000000017.

PMID:
24390274
10.

Income inequality and treatment of African American men with high-risk prostate cancer.

Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D'Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL.

Urol Oncol. 2015 Jan;33(1):18.e7-13. doi: 10.1016/j.urolonc.2014.09.005.

PMID:
25306287
11.

Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base.

Esnaola NF, Stewart AK, Feig BW, Skibber JM, Rodriguez-Bigas MA.

Ann Surg Oncol. 2008 Nov;15(11):3036-47. doi: 10.1245/s10434-008-0106-9.

PMID:
18712449
12.

Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.

Holmes L Jr, Chan W, Jiang Z, Ward D, Essien EJ, Du XL.

Cancer Control. 2009 Apr;16(2):176-85.

PMID:
19337204
13.

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

Schmid M, Meyer CP, Reznor G, Choueiri TK, Hanske J, Sammon JD, Abdollah F, Chun FK, Kibel AS, Tucker-Seeley RD, Kantoff PW, Lipsitz SR, Menon M, Nguyen PL, Trinh QD.

JAMA Oncol. 2016 Jan;2(1):85-93. doi: 10.1001/jamaoncol.2015.3384.

PMID:
26502115
14.

Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands.

Shavers VL, Harlan LC, Winn D, Davis WW.

Cancer Metastasis Rev. 2003 Mar;22(1):25-38.

PMID:
12716034
15.

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Lathan C, Kim SP, Trinh QD, Nguyen PL.

Urol Oncol. 2014 Nov;32(8):1285-91. doi: 10.1016/j.urolonc.2014.04.014.

PMID:
24846344
16.

Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population.

Hosain GM, Sanderson M, Du XL, Chan W, Strom SS.

Am J Mens Health. 2012 May;6(3):249-57. doi: 10.1177/1557988311432467.

PMID:
22419652
17.

Race/ethnicity and the perception of the risk of developing prostate cancer.

Shavers VL, Underwood W, Moser RP.

Am J Prev Med. 2009 Jul;37(1):64-7. doi: 10.1016/j.amepre.2009.03.007.

PMID:
19423272
18.

Population-Based Assessment of Determining Treatments for Prostate Cancer.

Chamie K, Williams SB, Hu JC.

JAMA Oncol. 2015 Apr;1(1):60-7. doi: 10.1001/jamaoncol.2014.192.

PMID:
26182305
19.

Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM Jr, Lucia MS, Kristal AR.

JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513. Erratum in: JAMA Oncol. 2015 Jun;1(3):322.

PMID:
26181184
20.

Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.

Carson AP, Howard DL, Carpenter WR, Taylor YJ, Peacock S, Schenck AP, Godley PA.

J Pain Symptom Manage. 2010 May;39(5):872-81. doi: 10.1016/j.jpainsymman.2009.09.013.

PMID:
20471547
Items per page

Supplemental Content

Support Center